Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
DNMR Transcript
Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
Unknown11-20
The earnings call reveals declining revenue and significant financial risks, including a gross loss and high debt levels. Despite partnerships and cost-saving initiatives, the negative impact of Starbucks' reallocation and lack of liquidity guidance are concerning. The Q&A section did not provide clarity, furthering uncertainties. While there are positive developments like partnerships and cost savings, these are overshadowed by financial instability and operational risks. The absence of a clear liquidity outlook and unresolved leadership transition contribute to a negative sentiment.
Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript
Unknown8-10
The earnings call reveals several challenges: a significant revenue decline, negative EBITDA guidance, and supply chain issues impacting results. Despite optimistic future PHA revenue forecasts and cost-saving measures, competitive pressures, regulatory disruptions, and liquidity concerns pose risks. The Q&A session highlighted management's vague responses, adding uncertainty. The warrant program's potential benefits are overshadowed by a high debt burden. Overall, the negative financial performance and management's unclear guidance suggest a negative stock price movement in the short term.
Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript
Unknown5-8
The earnings call indicates several challenges: significant revenue decline due to external conflicts, high debt levels, and liquidity concerns. While PHA revenues increased, overall sales dropped, and financial losses persist. The unresolved DOE loan adds uncertainty, and management's vague responses in the Q&A further dampen confidence. Despite some cost reductions and potential future operational improvements, the immediate outlook is negative, likely leading to a stock price decline.
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
Unknown3-28
The earnings call summary presents a mixed picture: positive developments such as potential DOE loan approval, strong demand, and cost reductions are offset by unclear guidance and the need for additional equity. The Q&A reveals optimism about future demand and partnerships but also highlights uncertainties in execution timing and financial commitments. Without specific guidance and given the lack of market cap data, the sentiment remains neutral.
DNMR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
